探索阻塞性睡眠呼吸暂停对肝硬化的影响:综合性综述
Zahra Dossaji1, Rajan Amin2, Vignan Manne2
1Department of Internal Medicine.
Journal of clinical gastroenterology
|March 19, 2025
概括
阻塞性睡眠呼吸暂停 (OSA) 与肝硬化风险更高有关. 持续的正气道压力 (CPAP) 可能会减缓肝病的进展,强调需要在肝脏患者中进行OSA查.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 睡眠医学 睡眠医学
- 内部医学 内部医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 已有充分证据表明,它会影响与代谢功能障碍相关的脂肪性肝病 (MASLD).
- 关于OSA与其他形式的慢性肝病,特别是肝硬化之间的联系的研究有限.
- 未被诊断的OSA可能会加速现有的肝病的进展.
研究的目的:
- 审查关于阻塞性睡眠呼吸暂停 (OSA) 和肝硬化之间的关系的现有文献.
- 探索OSA在肝病进展中的潜在作用.
- 鉴定肝病患者睡眠障碍查和管理的需要.
主要方法:
- 对调查OSA和肝硬化研究的系统文献综述.
- 分析目前关于OSA在肝病患者中患病率和影响的数据.
- 评估持续正气道压力 (CPAP) 治疗的潜在益处.
主要成果:
- 患有OSA的人患肝病的患病率更高.
- 持续的正气道压力 (CPAP) 治疗可以减轻肝病的进展.
- 对于肝病和BMI超过30的患者,建议对睡眠障碍进行查.
结论:
- OSA与肝硬化增加的可能性有关.
- 早期发现和治疗OSA对于改善肝病患者的治疗结果至关重要.
- 解决睡眠障碍可以改善患者的福祉和肝脏疾病管理.
相关概念视频
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Sleep Apnea
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...


